ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Book value per share
ResMed Inc.'s book value per share at the end of fiscal 2026 was 45.3×, up 11.3% from 40.7× in fiscal 2025. At the end of the quarter to 30 September 2026 it was 41.6×. Over the past ten years it has ranged from 11.3× (fiscal 2015) to 45.3× (fiscal 2026) — the current reading is the highest in ten years. ResMed Inc. ranks 9th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 45.3× | 11.25% |
| FY2025 | 40.7× | 22.95% |
| FY2024 | 33.1× | 17.57% |
| FY2023 | 28.1× | 22.30% |
| FY2022 | 23.0× | 15.86% |
| FY2021 | 19.9× | 14.79% |
| FY2020 | 17.3× | 19.48% |
| FY2019 | 14.5× | 0.40% |
| FY2018 | 14.4× | 4.00% |
| FY2017 | 13.9× | 14.75% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 41.6× | (8.08%) |
| Jun 2026 | 45.3× | 1.31% |
| Mar 2026 | 44.7× | 3.06% |
| Dec 2025 | 43.3× | 3.50% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BDX Becton, Dickinson and Company compare | 88.9× |
| ALGN Align Technology, Inc. compare | 60.6× |
| ALC Alcon compare | 44.4× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| WST West Pharmaceutical Services, Inc. compare | 42.2× |
| RMD ResMed Inc. | 41.6× |
| SOLV Solventum Corporation compare | 28.1× |
| MDLN Medline Inc. compare | 22.1× |
| BAX Baxter International Inc. compare | 12.5× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement